Chinese Medicine

Papers
(The H4-Index of Chinese Medicine is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China110
What we already know about rhubarb: a comprehensive review85
Tea and tea drinking: China’s outstanding contributions to the mankind71
The potential insights of Traditional Chinese Medicine on treatment of COVID-1958
Reflections on treatment of COVID-19 with traditional Chinese medicine57
Applications, phytochemistry, pharmacological effects, pharmacokinetics, toxicity of Scutellaria baicalensis Georgi. and its probably potential therapeutic effects on COVID-19: a review53
Quality standard of traditional Chinese medicines: comparison between European Pharmacopoeia and Chinese Pharmacopoeia and recent advances50
Flavonoids on diabetic nephropathy: advances and therapeutic opportunities48
Network pharmacology based research into the effect and mechanism of Yinchenhao Decoction against Cholangiocarcinoma46
Traditional application and modern pharmacological research of Eucommia ulmoides Oliv.45
Mechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking44
Traditional Chinese medicine for anti-Alzheimer’s disease: berberine and evodiamine from Evodia rutaecarpa39
Honokiol alleviates LPS-induced acute lung injury by inhibiting NLRP3 inflammasome-mediated pyroptosis via Nrf2 activation in vitro and in vivo38
Pharmacological activities and mechanisms of action of Pogostemon cablin Benth: a review38
The mechanism of electroacupuncture for depression on basic research: a systematic review36
Salidroside attenuates neuronal ferroptosis by activating the Nrf2/HO1 signaling pathway in Aβ1-42-induced Alzheimer’s disease mice and glutamate-injured HT22 cells35
Traditional Chinese Medicine for adjuvant treatment of breast cancer: Taohong Siwu Decoction34
Advances in the study of emodin: an update on pharmacological properties and mechanistic basis33
Plant metabolomics: a new strategy and tool for quality evaluation of Chinese medicinal materials32
Propolis: An update on its chemistry and pharmacological applications32
Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases32
Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment?30
Anti-inflammatory properties of uvaol on DSS-induced colitis and LPS-stimulated macrophages30
Natural drug sources for respiratory diseases from Fritillaria: chemical and biological analyses30
Anemoside B4 ameliorates TNBS-induced colitis through S100A9/MAPK/NF-κB signaling pathway29
Neurobiological effects of gallic acid: current perspectives29
Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives29
Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities28
0.037347793579102